Katrien Reynders

Board Member • Holland BIO

Katrien Reynders-Frederix is the former CEO of Pan Cancer T, a biotech developing TCR T-cell therapies for challenging solid tumours, and Board member of Holland Bio, an organisation representing the interests of the dutch biotech. Katrien has a great passion for translating breakthrough science into innovative treatments with commercial potential. Prior Pan Cancer T, she accumulated 20 years of experience in the biopharmaceutical industry from preclinical to market access, where she successfully led international drug development teams and global programs, particularly in the field of immune oncology. 


Also speaking

Elisabetta Zanon

Director of EU Public Affairs & Advocacy • Alliance for Regenerative Medicine

Stefanie Urlinger

Chief Scientific Officer • Cimeio Therapeutics

Stuart Curbishley

Chief Manufacturing & Development Officer • adthera bio

Event Info


Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.


Find out more about partnering at Advanced Therapies Europe.